BREAKTHROUGH PANCREATIC CANCER TREATMENT PHASE III TRIAL OPENS IN ISRAEL
Rafael Pharmaceuticals launched a phase III clinical trial on Thursday for pancreatic cancer at eight sites throughout Israel. The primary investigator is Dr. Talia Golan, head of Sheba Medical Center’s Pancreatic Cancer Center.
“It’s exciting to see the growth of cancer metabolism in the region, following the strides that has been...